Oliveira Aline Ferreira, Coelho Paulo S R
Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Avenida dos Bandeirantes 3900, Ribeirão Preto, SP, 14049-900, Brasil.
Universidade Paulista, Ribeirão Preto, SP, Brasil.
Methods Mol Biol. 2017;1625:213-224. doi: 10.1007/978-1-4939-7104-6_14.
Paracoccidioidomycosis (PCM) represents the most frequent systemic mycosis in Latin American. The disease is caused by the pathogenic thermally dimorphic fungus Paracoccidioides brasiliensis, and is initially characterized by pulmonary lesions, which can subsequently disseminate to other organs, resulting in secondary injuries. Although its high incidence, there is no commercially available vaccine against fungal diseases. A novel strategy, using Saccharomyces cerevisiae yeast as a vehicle for immunization against PCM, was recently successfully described. Herein, we describe strategies for the construction of the suitable S. cerevisiae vaccine, and protocols of administration and evaluation of the efficacy of the vaccine against experimental PCM.
副球孢子菌病(PCM)是拉丁美洲最常见的系统性真菌病。该疾病由致病性双态真菌巴西副球孢子菌引起,最初表现为肺部病变,随后可扩散至其他器官,导致继发性损伤。尽管其发病率很高,但尚无针对真菌疾病的商业可用疫苗。最近成功描述了一种新策略,即使用酿酒酵母作为针对PCM的免疫载体。在此,我们描述了构建合适的酿酒酵母疫苗的策略,以及该疫苗针对实验性PCM的给药方案和疗效评估方案。